DMV Liver Transplant Anesthesia Meeting 2022

April 23, 2022

This SATA regional meeting provides the audience with updated knowledge on several critical management issues in the liver transplant patients population.

 

Target Audience

Specialists working in the area of organ transplantation (ex., transplant anesthesiologists, intensivists, transplant surgeons, other transplant medicine specialists, and CRNAs); Trainees (ex., residents, fellows); Students (medical students, nursing students)

Learning Objectives

  • Discuss post operative pain management of the donor in a living donor liver transplant (LDLT).
  • Discuss the management of post reperfusion coagulopathy and choice of vasoactive drugs during orthotopic liver transplantation (OLT).
  • Review the pathophysiology and the impact of Cirrhotic Cardiomyopathy and Sickle Cell disease in the liver transplant population.
  • Discuss the surgical criteria for matching candidates to liver transplant and graft.
  • Share the clinical experience in challenging OLT cases.
  • Debate the pros and cons of having a dedicated ICU for liver transplant patients

Additional Information

AttachmentSize
File DMV LTA 2022 Syllabus - Program Final 032922_0 (1).docx53.44 KB
Course summary
Available credit: 
  • 4.00 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 4.00 Attendance
Course opens: 
04/23/2022
Course expires: 
12/31/2022
Event starts: 
04/23/2022 - 8:25am EDT
Event ends: 
04/23/2022 - 12:45pm EDT
Add to calendar: 
Virtual Conference
United States

All individuals in a position to control the content of this education activity have disclosed all financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships for the individuals listed below have been mitigated:

  • Tetsuro Sakai, MD, PhD, MHA: Springer Inc. (Book royalty), Haemonetics Inc (Grant/Research Support)
  • Aliaksei Pustavoitau, MD: Equity ownership in CoapTech; Stock ownership in GE, Butterfly Network, Sana Biotechnology, Moderna, AstraZeneca, eHealth, and Atea Pharmaceuticals
  • Megan Rashid, MD: Baxter Brazil (Lecturer)

No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

In support of improving patient care, this activity has been planned and implemented by the University of Pittsburgh and SATA. The University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh Medical Center designates this live activity for a maximum of 4 Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Available Credit

  • 4.00 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 4.00 Attendance
Please login or register to take this course.